EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Adenosine deaminase type 2 deficiency: From rare to common

Marjon Wouters iD, Verena Kienapfel iD, Lisa Ehlers iD, Hasan Hashem iD, Ivona Aksentijevich iD, Isabelle Meyts iD

Journal of Human Immunity · 07.09.2026 · 2 (5)

DOI: 10.70962/jhi.20260015 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Human Immunity, online erschienen am 03.08.2026. Verfasst von Marjon Wouters und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Inborn Errors of Immunity, Microbiology Immunology and Transplantation, KU Leuven, Leuven, Belgium. Die Arbeit nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Foundation – Flanders, Charité – Universitätsmedizin Berlin, Berlin Institute of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deficiency of adenosine deaminase type 2 (DADA2) is an inborn error of immunity caused by biallelic pathogenic variants in the ADA2 gene. DADA2 is characterized by a broad spectrum of clinical features, including inflammatory/vasculitic, hematological, and immunodeficient manifestations. Related to this complex clinical phenotype, which overlaps with other diseases, underdiagnosis of DADA2 can be suspected. Several pathophysiological mechanisms causing DADA2 have been described in recent years; however, a unifying pathomechanism explaining all DADA2 disease manifestations is still lacking. Although DADA2 is considered an autosomal recessive disorder, recently several variants in the ADA2 gene were described to cause DADA2 disease in a heterozygous state, via negative dominance. Data from PheWAS studies in large public databases support this observation. Based on these findings, the prevalence of ADA2-associated phenotypes might be much higher than the estimated 1 in 222,146 individuals. As a result, patients with these phenotypes are likely to be encountered by multiple medical disciplines.

Autor:innen und Institutionen

  • Laboratory for Inborn Errors of Immunity, Microbiology Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • German Center for Child and Adolescent Health (DZKJ), Partner Site Berlin, Berlin, Germany.
  • Deutsches Rheuma-Forschungszentrum, An Institute of the Leibniz Association, Berlin, Germany.
  • Department of Pediatrics, Division of Pediatric Hematology-Oncology, King Hussein Cancer Center (KHCC), Amman, Jordan.

ORCID-Profile: Marjon Wouters, Verena Kienapfel, Lisa Ehlers, Hasan Hashem, Ivona Aksentijevich, Isabelle Meyts

Förderung

  • Research Foundation – Flanders
  • Charité – Universitätsmedizin Berlin
  • Berlin Institute of Health

Zitieren

APA

Wouters, M., Kienapfel, V., Ehlers, L., Hashem, H., Aksentijevich, I., & Meyts, I. (2026). Adenosine deaminase type 2 deficiency: From rare to common. Journal of Human Immunity, 2(5). https://doi.org/10.70962/jhi.20260015

Vancouver

Wouters M, Kienapfel V, Ehlers L, Hashem H, Aksentijevich I, Meyts I. Adenosine deaminase type 2 deficiency: From rare to common. Journal of Human Immunity. 2026;2(5). doi:10.70962/jhi.20260015

BibTeX
@article{Wouters2026,
  author = {Wouters, Marjon and Kienapfel, Verena and Ehlers, Lisa and Hashem, Hasan and Aksentijevich, Ivona and Meyts, Isabelle},
  title = {Adenosine deaminase type 2 deficiency: From rare to common},
  journal = {Journal of Human Immunity},
  year = {2026},
  volume = {2},
  number = {5},
  doi = {10.70962/jhi.20260015}
}
Kostenlos starten →